FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors

Neuroendocrine tumors (NETs) are highly vascularized neoplasms. While FOLFOX chemotherapy has shown efficacy in patients with advanced NETs, its combination with antiangiogenics has been scarcely described. Here, we report the efficacy and tolerance of FOLFOX‐bevacizumab in this setting. We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacombe, Caroline, Perrier, Marine, Hentic, Olivia, Brixi, Hedia, De Rycke, Ophélie, Cros, Jérôme, Rebours, Vinciane, Cadiot, Guillaume, Ruszniewski, Philippe, de Mestier, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Translational and Clinical Neuroendocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078167/
https://www.ncbi.nlm.nih.gov/pubmed/36599808
http://dx.doi.org/10.1111/jne.13227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078167/
https://www.ncbi.nlm.nih.gov/pubmed/36599808
http://dx.doi.org/10.1111/jne.13227

Ejemplares similares